pcDNA3.1(+)/Luc2=tdT Citations (24)
Originally described in: Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.Patel MR, Chang YF, Chen IY, Bachmann MH, Yan X, Contag CH, Gambhir SS Cancer Res. 2010 Dec 15;70(24):10141-9. PubMed Journal
Articles Citing pcDNA3.1(+)/Luc2=tdT
| Articles |
|---|
| ThermoMouse: an in vivo model to identify modulators of UCP1 expression in brown adipose tissue. Galmozzi A, Sonne SB, Altshuler-Keylin S, Hasegawa Y, Shinoda K, Luijten IH, Chang JW, Sharp LZ, Cravatt BF, Saez E, Kajimura S. Cell Rep. 2014 Dec 11;9(5):1584-93. doi: 10.1016/j.celrep.2014.10.066. Epub 2014 Nov 26. PubMed |
| Differential fates of biomolecules delivered to target cells via extracellular vesicles. Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, Wang A, Sylvester MD, Schmidt TL, Kaspar RL, Butte MJ, Matin AC, Contag CH. Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):E1433-42. doi: 10.1073/pnas.1418401112. Epub 2015 Feb 23. PubMed |
| Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay. Liu L, Zhang SX, Aeran R, Liao W, Lu M, Polovin G, Pone EJ, Zhao W. Stem Cell Res Ther. 2015 Sep 21;6:181. doi: 10.1186/s13287-015-0151-9. PubMed |
| Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1. Qian L, Bradford AM, Cooke PH, Lyons BA. J Mol Recognit. 2016 Jul;29(7):318-33. doi: 10.1002/jmr.2533. Epub 2016 Feb 12. PubMed |
| Involvement of a Rac1-Dependent Macropinocytosis Pathway in Plasmid DNA Delivery by Electrotransfection. Mao M, Wang L, Chang CC, Rothenberg KE, Huang J, Wang Y, Hoffman BD, Liton PB, Yuan F. Mol Ther. 2017 Mar 1;25(3):803-815. doi: 10.1016/j.ymthe.2016.12.009. Epub 2017 Jan 24. PubMed |
| Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals. Liu J, Shen JX, He, Zhang GJ. Mol Imaging Biol. 2018 Oct;20(5):761-770. doi: 10.1007/s11307-018-1180-4. PubMed |
| GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Takaku M, Grimm SA, Roberts JD, Chrysovergis K, Bennett BD, Myers P, Perera L, Tucker CJ, Perou CM, Wade PA. Nat Commun. 2018 Mar 13;9(1):1059. doi: 10.1038/s41467-018-03478-4. PubMed |
| An orthotopic glioblastoma animal model suitable for high-throughput screenings. Pudelko L, Edwards S, Balan M, Nyqvist D, Al-Saadi J, Dittmer J, Almlof I, Helleday T, Brautigam L. Neuro Oncol. 2018 Oct 9;20(11):1475-1484. doi: 10.1093/neuonc/noy071. PubMed |
| Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer. Choi AH, O'Leary MP, Lu J, Kim SI, Fong Y, Chen NG. Mol Ther Oncolytics. 2018 Apr 5;9:22-29. doi: 10.1016/j.omto.2018.04.001. eCollection 2018 Jun 29. PubMed |
| Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer. Chen B, Yu J, Lu L, Dong F, Zhou F, Tao X, Sun E. Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26. PubMed |
| AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma. Das I, Gad H, Brautigam L, Pudelko L, Tuominen R, Hoiom V, Almlof I, Rajagopal V, Hansson J, Helleday T, Egyhazi Brage S, Warpman Berglund U. Cell Death Differ. 2020 Jul;27(7):2081-2098. doi: 10.1038/s41418-019-0488-1. Epub 2020 Jan 9. PubMed |
| Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis. Shah N, Liu Z, Tallman RM, Mohammad A, Sprowls SA, Saralkar PA, Vickers SD, Pinti MV, Gao W, Lockman PR. BMC Cancer. 2020 Apr 7;20(1):292. doi: 10.1186/s12885-020-06808-2. PubMed |
| High-Resolution Imaging of Tumor Spheroids and Organoids Enabled by Expansion Microscopy. Edwards SJ, Carannante V, Kuhnigk K, Ring H, Tararuk T, Hallbook F, Blom H, Onfelt B, Brismar H. Front Mol Biosci. 2020 Sep 24;7:208. doi: 10.3389/fmolb.2020.00208. eCollection 2020. PubMed |
| Human Somatostatin SST4 Receptor Transgenic Mice: Construction and Brain Expression Pattern Characterization. Nemes B, Bolcskei K, Kecskes A, Kormos V, Gaszner B, Aczel T, Hegedus D, Pinter E, Helyes Z, Sandor Z. Int J Mol Sci. 2021 Apr 4;22(7). pii: ijms22073758. doi: 10.3390/ijms22073758. PubMed |
| The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion. Xu Q, Zhang J, Telfer BA, Zhang H, Ali N, Chen F, Risa B, Pearson AJ, Zhang W, Finegan KG, Ucar A, Giurisato E, Tournier C. Oncogene. 2021 Jun;40(23):3929-3941. doi: 10.1038/s41388-021-01798-2. Epub 2021 May 12. PubMed |
| IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation. Amobi-McCloud A, Muthuswamy R, Battaglia S, Yu H, Liu T, Wang J, Putluri V, Singh PK, Qian F, Huang RY, Putluri N, Tsuji T, Lugade AA, Liu S, Odunsi K. Front Immunol. 2021 Apr 16;12:678999. doi: 10.3389/fimmu.2021.678999. eCollection 2021. PubMed |
| Nucleic Acid Delivery from Granular Hydrogels. Kurt E, Segura T. Adv Healthc Mater. 2022 Feb;11(3):e2101867. doi: 10.1002/adhm.202101867. Epub 2021 Nov 23. PubMed |
| LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. Su MT, Kumata S, Endo S, Okada Y, Takai T. Oncoimmunology. 2022 Apr 5;11(1):2060907. doi: 10.1080/2162402X.2022.2060907. eCollection 2022. PubMed |
| Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth. Zisi A, Kanellis DC, Moussaud S, Karlsson I, Caren H, Brautigam L, Bartek J, Lindstrom MS. Neuro Oncol. 2023 Jun 2;25(6):1058-1072. doi: 10.1093/neuonc/noac286. PubMed |
| Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Kanellis DC, Zisi A, Skrott Z, Lemmens B, Espinoza JA, Kosar M, Bjorkman A, Li X, Arampatzis S, Bartkova J, Andujar-Sanchez M, Fernandez-Capetillo O, Mistrik M, Lindstrom MS, Bartek J. Cell Death Differ. 2023 Jul;30(7):1666-1678. doi: 10.1038/s41418-023-01167-4. Epub 2023 May 4. PubMed |
| Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival. Jeethy Ram T, Lekshmi A, Darvin P, Rajappan P, Jagathnath Krishna KM, Anoop TM, Augustine P, Mathew AP, Cherian K, Bhargavan RV, Somanathan T, Radhakrishna Pillai M, Santhosh Kumar TR, Sujathan K. Tumour Biol. 2023;45(1):31-54. doi: 10.3233/TUB-230002. PubMed |
| Mobility gene expression differences among wild-type, Mmp20 null and Mmp20 over-expresser mice plus visualization of 3D mouse ameloblast directional movement. Shin M, Matsushima A, Nagao JI, Tanaka Y, Harada H, Okabe K, Bartlett JD. Sci Rep. 2023 Nov 1;13(1):18829. doi: 10.1038/s41598-023-44627-0. PubMed |
| Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Sarrett SM, Rodriguez C, Delaney S, Hosny MM, Sebastiano J, Santos-Coquillat A, Keinanen OM, Carter LM, Lastwika KJ, Lampe PD, Zeglis BM. Mol Pharm. 2024 Mar 4;21(3):1402-1413. doi: 10.1021/acs.molpharmaceut.3c01063. Epub 2024 Feb 8. PubMed |
| Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo. Zheng D, Elnegiry AA, Luo C, Bendahou MA, Xie L, Bell D, Takahashi Y, Hanna E, Mias GI, Tsoi MF, Gu B. Life Sci Alliance. 2024 May 9;7(7):e202402602. doi: 10.26508/lsa.202402602. Print 2024 Jul. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.